Company news
Lifeward Ltd. news in 2025
Lifeward Ltd.'s news releases, calls and decks from 2025, newest first.
Lifeward Appoints Bob Marshall as Chairman of the Board
December 19, 2025
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
December 17, 2025
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
December 3, 2025
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
November 17, 2025
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
November 14, 2025
Lifeward to Report Third Quarter Financial Results on November 14, 2025
November 10, 2025
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
September 9, 2025
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
September 8, 2025
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
August 14, 2025
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
August 13, 2025
Lifeward to Report Second Quarter Financial Results on August 14, 2025
August 7, 2025
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
August 4, 2025
MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
July 7, 2025
Lifeward Announces Closing of $2.6 Million Public Offering
June 26, 2025
Lifeward Announces Pricing of $2.6 Million Public Offering
June 25, 2025
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
June 24, 2025
Lifeward Names Mark Grant as New CEO
May 19, 2025
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
May 19, 2025
Lifeward Ltd. Reports First Quarter 2025 Financial Results
May 15, 2025
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
May 8, 2025
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
May 7, 2025
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
April 29, 2025
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
April 24, 2025
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
April 15, 2025
FDA Issues Clearance for ReWalk 7 Exoskeleton
March 13, 2025
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
March 7, 2025
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
March 6, 2025
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
March 5, 2025
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
February 28, 2025
Lifeward Announces CEO Transition
February 19, 2025
Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
February 4, 2025
Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
February 3, 2025
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
January 12, 2025
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
January 12, 2025
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 6, 2025